The step to curing Crohn's disease and ulcerative colitis may be closer than we think.
Canadian drug development company Qu Biologic and McMaster University have been working towards finding a way to put Crohn's disease and ulcerative colitis into remission using new methods that boost the human immune system, rather than suppress it.
Dr. Hal Gunn is the CEO of Qu Biologic and explains that he treatment that he is working helps boost the innate immune system, and is currently in phase 2 of human testing.
Dr.Gunn says that from what he's seen so far, patients will see a 50% remission rate within 8 weeks of treatment, and after 52 weeks the disease is practically gone.
Dr. Gunn adds that this research couldn't have been done without the help of McMaster University.
He says that if you live within 2-3 hours of the McMaster campus and live with Crohn's or colitis, you can visit quibd.com (Q-U-I-B-D .com) to join the clinical trials.